137 related articles for article (PubMed ID: 12891371)
21. System-ready scientists.
Alvarez M
Nature; 2007 May; 447(7144):612. PubMed ID: 17563936
[No Abstract] [Full Text] [Related]
22. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
23. How much return does that PhD provide?
Manag Care; 2011 Jul; 20(7):13. PubMed ID: 21848194
[No Abstract] [Full Text] [Related]
24. An Opportunity for Industry-Academia Partnership: Training the Next Generation of Industrial Researchers in Characterizing Higher Order Protein Structure.
Bain DL; Brenowitz M; Roberts CJ
J Pharm Sci; 2016 Dec; 105(12):3483-3486. PubMed ID: 27671238
[TBL] [Abstract][Full Text] [Related]
25. 3 drug firms to cut thousands of jobs.
Scott L
Mod Healthc; 1993 Oct; 23(43):8. PubMed ID: 10129378
[No Abstract] [Full Text] [Related]
26. Wanted: social entrepreneurs.
Nature; 2005 Apr; 434(7036):941. PubMed ID: 15846306
[No Abstract] [Full Text] [Related]
27. Collaborative research training.
Amidon GL
Mol Pharm; 2005; 2(2):97. PubMed ID: 15804183
[No Abstract] [Full Text] [Related]
28. Are graduate programs training pharmaceutical scientists to function effectively in the new, highly integrated and globalized pharmaceutical industry?
Borchardt RT
Pharm Res; 1997 May; 14(5):554-5. PubMed ID: 9165523
[No Abstract] [Full Text] [Related]
29. The role of medicinal chemists in drug discovery.
Greenlee WJ; Desai MC
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):419-20. PubMed ID: 16022177
[No Abstract] [Full Text] [Related]
30. [Public health and chemical-pharmaceutical companies].
Ribeiro MA
Hist Cienc Saude Manguinhos; 2000 Nov-2001 Feb; 7(3):607-26. PubMed ID: 16683337
[TBL] [Abstract][Full Text] [Related]
31. A route to flexible working.
Smaglik P; Smith A
Nature; 2002 Feb; 415(6872):4-6. PubMed ID: 11832890
[No Abstract] [Full Text] [Related]
32. ABPI/Bioscience Federation 'In vivo sciences in the UK: sustaining the supply of skills in the 21st century': fast-tracking a u-turn.
Stanford SC
J Psychopharmacol; 2008 Mar; 22(2):117-8. PubMed ID: 18332049
[No Abstract] [Full Text] [Related]
33. Networking, networking, networking, networking, networking.
Watanabe M
Nature; 2004 Aug; 430(7001):812-3. PubMed ID: 15306820
[No Abstract] [Full Text] [Related]
34. Thinking ahead.
Smaglik P
Nature; 2003 May; 423(6939):565. PubMed ID: 12774127
[No Abstract] [Full Text] [Related]
35. Growth industry.
Lewis R
Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
[No Abstract] [Full Text] [Related]
36. Analyse this.
Powell K
Nature; 2004 Oct; 431(7010):880-1. PubMed ID: 15483620
[No Abstract] [Full Text] [Related]
37. Toronto rising.
Kleiner K
Nature; 2008 May; 453(7192):252-3. PubMed ID: 18561361
[No Abstract] [Full Text] [Related]
38. Where will we get the next generation of medicinal chemists?
Allen D
Drug Discov Today; 2016 May; 21(5):704-6. PubMed ID: 27131748
[No Abstract] [Full Text] [Related]
39. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
40. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]